ARTUSI, CARLO ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 1.907
AS - Asia 1.113
EU - Europa 947
SA - Sud America 132
AF - Africa 65
OC - Oceania 5
Totale 4.169
Nazione #
US - Stati Uniti d'America 1.857
SG - Singapore 495
RU - Federazione Russa 397
IT - Italia 311
CN - Cina 170
VN - Vietnam 156
HK - Hong Kong 106
BR - Brasile 94
BD - Bangladesh 60
GB - Regno Unito 52
DE - Germania 37
FR - Francia 33
FI - Finlandia 23
CA - Canada 22
NL - Olanda 22
IN - India 18
ID - Indonesia 16
KR - Corea 15
MX - Messico 15
IQ - Iraq 14
ZA - Sudafrica 13
NG - Nigeria 12
BJ - Benin 11
ES - Italia 10
AR - Argentina 9
AT - Austria 9
IE - Irlanda 9
JP - Giappone 9
PK - Pakistan 9
SE - Svezia 9
SA - Arabia Saudita 8
TG - Togo 8
TR - Turchia 8
EC - Ecuador 7
PL - Polonia 7
VE - Venezuela 7
MY - Malesia 6
PH - Filippine 6
UA - Ucraina 6
AU - Australia 5
CH - Svizzera 5
DZ - Algeria 5
CO - Colombia 4
MA - Marocco 4
PE - Perù 4
CL - Cile 3
EG - Egitto 3
HN - Honduras 3
SV - El Salvador 3
BE - Belgio 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
GE - Georgia 2
JO - Giordania 2
KE - Kenya 2
LT - Lituania 2
NP - Nepal 2
OM - Oman 2
PY - Paraguay 2
RO - Romania 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
BZ - Belize 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
LY - Libia 1
MD - Moldavia 1
NA - Namibia 1
NI - Nicaragua 1
NO - Norvegia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SL - Sierra Leone 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.169
Città #
Dallas 633
San Jose 502
Singapore 325
Council Bluffs 221
Verona 183
Ashburn 156
Moscow 146
Hong Kong 105
Ho Chi Minh City 55
New York 42
Hanoi 40
Beijing 24
Buffalo 23
Los Angeles 23
Milan 20
The Dalles 18
Chandler 13
London 13
Bologna 12
São Paulo 12
Cotonou 11
Santa Clara 11
Abuja 10
Helsinki 10
Lappeenranta 10
Amsterdam 9
Haiphong 9
Jakarta 9
Da Nang 8
Dublin 8
Lomé 8
Redondo Beach 8
Nuremberg 7
Phoenix 7
Rome 7
Southend 7
Tokyo 7
Baghdad 6
Montreal 6
Munich 6
Biên Hòa 5
Brooklyn 5
Cape Town 5
Caracas 5
Chicago 5
Des Moines 5
Geneva 5
Redmond 5
Toronto 5
Vienna 5
Atlanta 4
Falkenstein 4
Jacksonville 4
Kuala Lumpur 4
Madrid 4
Manchester 4
Mexico City 4
North Bergen 4
Poplar 4
Riyadh 4
Stockholm 4
Turin 4
Warsaw 4
Algiers 3
Belo Horizonte 3
City of London 3
Denver 3
Dhaka 3
Glasgow 3
Guangzhou 3
Islamabad 3
Jeddah 3
Kyiv 3
Lawrence 3
Marseille 3
Naples 3
Orem 3
Princeton 3
Rio de Janeiro 3
San Salvador 3
Santo André 3
Sydney 3
Turku 3
Ankara 2
Asunción 2
Bergamo 2
Birmingham 2
Bordeaux 2
Boydton 2
Brasília 2
Cairo 2
Can Tho 2
Catania 2
Changsha 2
Columbus 2
Cuenca 2
Dong Ket 2
Erbil 2
Frankfurt am Main 2
Gualdo Cattaneo 2
Totale 2.926
Nome #
The Influence of Genetics in the Early Development of Axial Postural Abnormalities in Parkinson's Disease 365
The Complex Pathway of Conventional Investigations before the Diagnosis of Functional Motor Disorders 351
Camera- and Viewpoint-Agnostic Evaluation of Axial Postural Abnormalities in People with Parkinson’s Disease through Augmented Human Pose Estimation 130
Assessment of axial postural abnormalities in Parkinsonism: automatic picture analysis software 128
Dynamic Video Assessment of Axial Postural Abnormalities in Parkinson's Disease: A Pilot Study 125
Axial postural abnormalities in Parkinsonism: gaps in predictors, pathophysiology, and management 120
Advances in diagnosis, classification, and management of pain in Parkinson's disease 117
Freezing of gait detection: The effect of sensor type, position, activities, datasets, and machine learning model 117
Does the degree of trunk bending predict patient disability, motor impairment, falls, and back pain in Parkinson's Disease? 106
Postural abnormalities in Parkinson's Disease: an epidemiological and clinical multicenter study 105
Botulinum toxin for axial postural abnormalities in Parkinson's Disease: a systematic review 100
Task force consensus on nosology and cut-off values for axial postural abnormalities in parkinsonism 98
Predictors and pathophysiology of axial postural abnormalities in Parkinsonism: a scoping review 94
Validity of the wall goniometer as a screening tool to detect postural abnormalities in Parkinson's disease 94
Longitudinal assessment of Botulinum Toxin treatment for lateral trunk flexion and Pisa Syndrome in Parkinson's Disease: real-life, long-term study 87
Visuospatial Deficits Are Associated with Pisa Syndrome and not Camptocormia in Parkinson's Disease 79
Clinical Algorithm-Guided Approach to Botulinum Toxin Type A Treatment for Axial Postural Abnormalities in Parkinson's Disease 79
Reply: "Human Pose Estimation Is Approximate: Limitations and Considerations for its Use in Clinical Trials" 72
Filling the gap in assessing pain in dystonia 70
Treatment of axial postural abnormalities in parkinsonism disorders: A systematic review of pharmacological, rehabilitative and surgical interventions 70
Placebo Responses in Trials of Functional Neurologic Disorders 39
A multi-level annotated sensor dataset of gait freezing manifestations and severity in Parkinson's disease 39
Unraveling the role of GBA1 genotype in axial signs response to subthalamic deep brain stimulation 36
Is segmental/multifocal onset a distinct presentation of idiopathic adult-onset dystonia? 29
Does sex influence the natural history of idiopathic adult-onset dystonia? 26
Long-Term Motor and Cognitive Outcome of Deep Brain Stimulation in Patients With Parkinson Disease With a GBA1 Pathogenic Variant 26
From RGB-D to RGB-Only: Reliability and Clinical Relevance of Markerless Skeletal Tracking for Postural Assessment in Parkinson’s Disease 24
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations 23
Gait and axial postural abnormalities correlations in Parkinson{'}s disease: A multicenter quantitative study 22
Digital work engagement among Italian neurologists 22
Unraveling the stride: exploring the influence of neurogenic orthostatic hypotension on gait and balance in Parkinson?s disease 21
A new index to assess turning quality and postural stability in patients with Parkinson{'}s disease 20
NoMoFa as a new tool to evaluate the impact of deep brain stimulation on non-motor fluctuations: A new perspective 20
Nonmotor fluctuations in Parkinson's disease: impact on caregiving and quality of life 20
Effect of deep brain stimulation frequency on gait symmetry, smoothness and variability using IMU 20
Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials 20
Editorial: Digital biomarkers in movement disorders 20
Multidisciplinary care use in neurodegenerative complex diseases: The example of progressive supranuclear palsy and advanced Parkinson's disease in real-life 20
Effects of dopaminergic therapy on sleep quality in fluctuating Parkinson?s disease patients 20
Burden of caregiving for cardiovascular dysautonomia in Parkinson?s disease 20
Long-term motor and cognitive outcome of Deep Brain Stimulation in GBA-PD: the Italian PARKNET study 20
Speech Impairment in Parkinson's Disease: Acoustic Analysis of Unvoiced Consonants in Italian Native Speakers 20
Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis 19
Active CMV infection in two patients with multiple sclerosis treated with alemtuzumab 19
Low frequency subthalamic stimulation and event-related potentials in Parkinson disease 19
15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson?s disease patient with Parkin gene mutation: a case report 18
Clinical MRI to predict motor and non-motor effects of deep brain stimulation in Parkinson disease 18
Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up 18
Botulinum toxin for Pisa syndrome: An MRI-, ultrasound- and electromyography-guided pilot study 18
The impact of dysphagia in Parkinson's disease patients treated with levodopa/carbidopa intestinal gel 18
The relationship between occupation and specific forms of idiopathic adult-onset dystonia 18
Subthalamic and Nigral Stimulation for Freezing of Gait in Parkinson disease: randomized pilot trial 17
Smartphone-Based Evaluation of Postural Stability in Parkinson’s Disease Patients During Quiet Stance 17
Pregnancy, fertile life factors, and associated clinical course in PRKN early-onset Parkinson?s disease 17
Deep brain stimulation outcomes in the malignant end of Parkinson's disease spectrum 17
Expanded and independent validation of the NoMoFA scale for Parkinson?s disease: the Italian version 17
Earlier versus later subthalamic deep brain stimulation in Parkinson's disease 17
Ventral tegmental area disconnection contributes two years early to correctly classify patients converted to alzheimer's disease: Implications for treatment 16
Subthalamic nucleus deep brain stimulation outcome in young onset Parkinson's disease: A role for age at disease onset? 16
(Re)configuration of digital health records to optimize diagnosis and therapy 16
Should we offer deep brain stimulation to Parkinson?s disease patients with GBA mutations? 16
Tuning deep brain stimulation related depression by frequency modulation: A case report 16
Association between sleep disorders and cognitive dysfunctions in non-demented patients with advanced Parkinson?s disease 16
The still under-investigated role of cognitive deficits in PML diagnosis 16
Incidence and predictors of postural abnormalities in Parkinson?s disease: a PPMI cohort study 16
Subthalamic deep brain stimulation and levodopa in Parkinson?s disease: a meta-analysis of combined effects 16
Parkinsonism-hyperpyrexia syndrome due to gastroparesis treated with subcutaneous foslevodopa: a case report 16
Orthostatic hypotension in Parkinson disease: Impact on health care utilization 15
Integration of technology-based outcome measures in clinical trials of Parkinson and other neurodegenerative diseases 15
Early reversible leukoencephalopathy and unilateral sixth cranial nerve palsy in mild {COVID}-19 infection 15
Levodopa/carbidopa intestinal gel infusion in advanced Parkinson's disease: A 7-year experience 15
Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort 15
Subthalamic deep brain stimulation and trunk posture in Parkinson's disease 15
Detection of Freezing of Gait in People with Parkinson{'}s Disease using Smartphones 15
Axial symptoms as main predictors of short-term subthalamic stimulation outcome in Parkinson{'}s disease 15
Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson{'}s disease 15
Postural abnormalities in Asian and Caucasian Parkinson{\textquotesingle}s disease patients: A multicenter study 15
Biomechanical assessment of botulinum toxin effects in Pisa syndrome disease 15
Levodopa-Induced Neuropathy: A Systematic Review 15
Natalizumab in multiple sclerosis: Long-term management 14
Deep brain stimulation fine-tuning in Parkinson's disease: Short pulse width effect on speech 14
CACNA1A variant associated with generalized dystonia 14
Ultrasound-guided botulinum toxin-a injections: A method of treating sialorrhea 14
Parkinson{'}s disease progression at 30 years: A study of subthalamic deep brain-stimulated patients 14
Medical therapy and subthalamic deep brain stimulation in advanced Parkinson{'}s disease: A different long-term outcome? 14
Safety and efficacy of tolcapone in Parkinson’s disease: systematic review 14
Behind the scenes: exploring neurological journal editors{'} work habits, decisions, and potential sources of conflict of interest 14
Beyond 10 years of levodopa intestinal infusion experience: Analysis of mortality and its predictors 14
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: Effects on involuntary movements 14
Pisa syndrome in Parkinson's disease is associated with specific cognitive alterations 14
Levodopa-Induced Dyskinesias and Dyskinesias-Reduced-Self-Awareness in Parkinson’s Disease: A Neurocognitive Approach 14
COVID-19 in Parkinson's disease: Report on prevalence and outcome 14
Identifying Poor Responders to STN DBS in Parkinson Disease: The Role of Rapid Disease Progression in the First Year in Optimal Responders to Levodopa 13
Prospective assessment of peripheral neuropathy in Duodopa-treated parkinsonian patients 13
Motor and non-motor outcomes of subthalamic deep brain stimulation in a case of juvenile PARK-PINK1 13
Early Detection of Dysphagia Signs in Parkinson’s Disease: An Artificial Intelligence-Based Approach Using Non-Invasive Sensors 13
Effects of intestinal Levodopa infusion on freezing of gait in Parkinson disease 13
Predictors of cognitive performance in idiopathic adult-onset dystonia 13
G325R GBA mutation in Parkinson's disease: Disease course and long- term DBS outcome 13
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic 13
Totale 3.927
Categoria #
all - tutte 18.327
article - articoli 18.094
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 233
Totale 36.654


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 0 4
2021/202213 0 3 0 0 0 0 0 2 0 1 2 5
2022/202351 3 8 4 5 4 10 1 2 3 4 4 3
2023/202478 5 3 6 9 8 21 8 2 0 4 6 6
2024/2025306 16 11 16 42 15 6 15 23 41 24 30 67
2025/20263.882 70 63 644 180 426 110 151 1.015 520 383 143 177
Totale 4.375